Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

被引:663
|
作者
Maguire, Albert M. [2 ,3 ]
High, Katherine A. [2 ,4 ,5 ,6 ]
Auricchio, Alberta [7 ,8 ]
Wright, J. Fraser [2 ,15 ]
Pierce, Eric A. [3 ]
Testa, Francesco [9 ]
Mingozzi, Federico [2 ]
Bennicelli, Jeannette L.
Ying, Gui-shuang [10 ]
Rossi, Settimio [9 ]
Fulton, Ann [11 ]
Marshall, Kathleen A. [2 ]
Banfi, Sandra [7 ]
Chung, Daniel C.
Morgan, Jessica I. W.
Hauck, Bernd [2 ]
Zelenaia, Olga [2 ]
Zhu, Xiaosong [3 ]
Raffini, Leslie [4 ]
Coppieters, Frauke [12 ]
De Baere, Elfride [12 ]
Shindler, Kenneth S.
Volpe, Nicholas J. [10 ]
Surace, Enrico M. [7 ]
Acerra, Carmela [9 ]
Lyubarsky, Arkady
Redmond, T. Michael [13 ]
Stone, Edwin [5 ,6 ,14 ]
Sun, Junwei [2 ]
McDonnell, Jennifer Wellman [2 ]
Leroy, Bart P. [12 ,16 ,17 ]
Simonelli, Francesca [9 ]
Bennett, Jean [1 ,2 ]
机构
[1] Univ Penn, Stellar Chance Labs 309C, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Abramson Pediat Res Ctr, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Dept Hematol, Dept Pediat, Philadelphia, PA 19104 USA
[5] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[6] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA
[7] TIGEM, Naples, Italy
[8] Univ Naples Federico 2, Dept Pediat, Naples, Italy
[9] Univ Naples 2, Dept Ophthalmol, Naples, Italy
[10] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Ctr Prevent Ophthalmol & Biostat, Philadelphia, PA 19104 USA
[11] Childrens Hosp Boston, Dept Ophthalmol, Boston, MA USA
[12] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium
[13] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA
[14] Univ Iowa, Coll Med, Dept Ophthalmol, Carver Ctr, Iowa City, IA 52242 USA
[15] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[16] Univ Ghent, Dept Ophthalmol, B-9000 Ghent, Belgium
[17] Ghent Univ Hosp, B-9000 Ghent, Belgium
来源
LANCET | 2009年 / 374卷 / 9701期
关键词
VISUAL CYCLE; RETINITIS-PIGMENTOSA; VISION; MUTATIONS; BLINDNESS; ROD; ISOMEROHYDROLASE; ISOMERASE; KINETICS; SAFETY;
D O I
10.1016/S0140-6736(09)61836-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Gene therapy has the potential to reverse disease or prevent further deterioration of vision in patients with incurable inherited retinal degeneration. We therefore did a phase 1 trial to assess the effect of gene therapy on retinal and visual function in children and adults with Leber's congenital amaurosis. Methods We assessed the retinal and visual function in 12 patients (aged 8-44 years) with RPE65-associated Leber's congenital amaurosis given one subretinal injection of adeno-associated virus (AAV) containing a gene encoding a protein needed for the isomerohydrolase activity of the retinal pigment epithelium (AAV2-hRPE65v2) in the worst eye at low (1.5x10(10) vector genomes), medium (4.8x10(10) vector genomes), or high dose (1.5x10(11) vector genomes) for up to 2 years. Findings AAV2-hRPE65v2 was well tolerated and all patients showed sustained improvement in subjective and objective measurements of vision (ie, dark adaptometry, pupillometry, electroretinography, nystagmus, and ambulatory behaviour). Patients had at least a 2 log unit increase in pupillary light responses, and an 8-year-old child had nearly the same level of light sensitivity as that in age-matched normal-sighted individuals. The greatest improvement was noted in children, all of whom gained ambulatory vision. The study is registered with ClinicalTrials.gov, number NCT00516477. Interpretation The safety, extent, and stability of improvement in vision in all patients support the use of AAV mediated gene therapy for treatment of inherited retinal diseases, with early intervention resulting in the best potential gain.
引用
收藏
页码:1597 / 1605
页数:9
相关论文
共 28 条
  • [1] Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
    Cideciyan, Artur V.
    Hauswirth, William W.
    Aleman, Tomas S.
    Kaushal, Shalesh
    Schwartz, Sharon B.
    Boye, Sanford L.
    Windsor, Elizabeth A. M.
    Conlon, Thomas J.
    Sumaroka, Alexander
    Pang, Ji-jing
    Roman, Alejandro J.
    Byrne, Barry J.
    Jacobson, Samuel G.
    HUMAN GENE THERAPY, 2009, 20 (09) : 999 - 1004
  • [2] Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis
    Rakoczy, Elizabeth P.
    Narfstroem, Kristina
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 56 : 153 - 157
  • [3] Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy
    Cideciyan, Artur V.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2010, 29 (05) : 398 - 427
  • [4] A Gene Scan Study of RPE65 in Chinese Patients with Leber Congenital Amaurosis
    Liu, Jing
    Bu, Juan
    CHINESE MEDICAL JOURNAL, 2017, 130 (22) : 2709 - 2712
  • [5] A Novel Mutation in the RPE65 Gene Causing Leber Congenital Amaurosis and Its Transcriptional Expression In Vitro
    Mo, Guoyan
    Ding, Qin
    Chen, Zhongshan
    Li, Yunbo
    Yan, Ming
    Bu, Lijing
    Song, Yanping
    Yin, Guohua
    PLOS ONE, 2014, 9 (11):
  • [6] Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial
    Francisco Chacon-Camacho, Oscar
    Carlos Zenteno, Juan
    GACETA MEDICA DE MEXICO, 2017, 153 (02): : 276 - 278
  • [7] Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis
    Stein, Linda
    Roy, Kamolika
    Lei, Lei
    Kaushal, Shalesh
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (03) : 429 - 439
  • [8] Impacts of two point mutations of RPE65 from Leber's congenital amaurosis on the stability, subcellular localization and isomerohydrolase activity of RPE65
    Chen, Ying
    Moiseyev, Gennadiy
    Takahashi, Yusuke
    Ma, Jian-xing
    FEBS LETTERS, 2006, 580 (17) : 4200 - 4204
  • [9] Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis
    Pang, JJ
    Chang, B
    Kumar, A
    Nusinowitz, S
    Noorwez, SM
    Li, J
    Rani, A
    Foster, TC
    Chiodo, VA
    Doyle, T
    Li, HS
    Malhotra, R
    Teusner, JT
    McDowell, JH
    Min, SH
    Li, QH
    Kaushal, S
    Hauswirth, WW
    MOLECULAR THERAPY, 2006, 13 (03) : 565 - 572
  • [10] Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark
    Astuti, Galuh D. N.
    Bertelsen, Mette
    Preising, Markus N.
    Ajmal, Muhammad
    Lorenz, Birgit
    Faradz, Sultana M. H.
    Qamar, Raheel
    Collin, Rob W. J.
    Rosenberg, Thomas
    Cremers, Frans P. M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2016, 24 (07) : 1071 - 1079